These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

68 related items for PubMed ID: 6219221

  • 1. Generalized skeletal response to 99mtechnetium methylene diphosphonate in rheumatoid arthritis.
    Helfgott S, Rosenthall L, Esdaile J, Tannenbaum H.
    J Rheumatol; 1982; 9(6):939-41. PubMed ID: 6219221
    [Abstract] [Full Text] [Related]

  • 2. Whole body retention of diphosphonate in rheumatoid arthritis.
    Steven MM, Sturrock RD, Fogelman I, Smith ML.
    J Rheumatol; 1982; 9(6):873-7. PubMed ID: 7161778
    [Abstract] [Full Text] [Related]

  • 3. [Biokinetics of osteotropic radiopharmaceuticals in metabolic osteopathy--comparison of 47Ca and 99mTc-methylene-diphosphonate (MDP)].
    Knop J, Montz R.
    Nuklearmedizin; 1983 Oct; 22(5):226-31. PubMed ID: 6228781
    [Abstract] [Full Text] [Related]

  • 4. [Local blood flow and bone uptake of methylene-diphosphonate-technetium-99m. 2].
    Vattimo A, Martini G.
    Boll Soc Ital Biol Sper; 1983 Nov 30; 59(11):1614-7. PubMed ID: 6230088
    [No Abstract] [Full Text] [Related]

  • 5. [Interaction between radiopharmaceutical and therapeutic agents. The modification of the distribution of 99mTc-methylene diphosphonate by D-penicillamine].
    Van de Flierdt E, Stumpf E, Bögl W.
    Nuklearmedizin; 1985 Apr 30; 24(2):82-6. PubMed ID: 3161001
    [Abstract] [Full Text] [Related]

  • 6. Rheumatoid arthritis: evidence for bone loss in premenopausal women.
    Tourinho TF, Stein A, Castro JA, Brenol JC.
    J Rheumatol; 2005 Jun 30; 32(6):1020-5. PubMed ID: 15940761
    [Abstract] [Full Text] [Related]

  • 7. Investigation of the metabolic acitivity of bone in rheumatoid arthritis.
    Rosenspire KC, Kennedy AC, Steinbach J, Blau M, Green FA.
    J Rheumatol; 1980 Jun 30; 7(4):469-73. PubMed ID: 6252321
    [Abstract] [Full Text] [Related]

  • 8. Global skeletal uptake of 99mTc-methylene diphosphonate (GSU) in patients affected by endocrine diseases: comparison with biochemical markers of bone turnover.
    Scillitani A, Dicembrino F, Chiodini I, Minisola S, Fusilli S, Di Giorgio A, Garrubba M, D'Aloiso L, Frusciante V, Torlontano M, Modoni S, Trischitta V, Trischitta V, Carnevale V.
    Osteoporos Int; 2002 Oct 30; 13(10):829-34. PubMed ID: 12378373
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Kinetics of 99mTc-tin-methylene diphosphonate in normal subjects and pathological conditions: a simple index of bone metabolism.
    Coupal JJ.
    Calcif Tissue Int; 1981 Oct 30; 33(5):555. PubMed ID: 6797708
    [No Abstract] [Full Text] [Related]

  • 11. Whole-body retention of 99mTc-MPD in Paget's disease.
    Vattimo A, Cantalupi D, Righi G, Martini G, Nuti R, Turchetti V.
    J Nucl Med Allied Sci; 1981 Oct 30; 25(1-2):5-10. PubMed ID: 6454766
    [No Abstract] [Full Text] [Related]

  • 12. [Renal excretion of methylene-diphosphate-technium-99m. Preliminary observations].
    Vattimo A, Martini G.
    Boll Soc Ital Biol Sper; 1983 Nov 30; 59(11):1649-53. PubMed ID: 6230089
    [Abstract] [Full Text] [Related]

  • 13. Studies of the chemical and biological properties of the skeletal imaging agent 99mTc-methylene diphosphonate.
    Vanlić-Razumenić N, Djokić D, Paunković N, Gorkić D.
    Nuklearmedizin; 1982 Aug 30; 21(4):150-6. PubMed ID: 6216460
    [No Abstract] [Full Text] [Related]

  • 14. Kinetics of 99mtechnetium-tin-methylene-diphosphonate in normal subjects and pathological conditions: a simple index of bone metabolism.
    Caniggia A, Vattimo A.
    Calcif Tissue Int; 1980 Aug 30; 30(1):5-13. PubMed ID: 6767533
    [No Abstract] [Full Text] [Related]

  • 15. Increased bone metabolism in rheumatoid arthritis as measured by the whole-body retention of 99Tcm methylene diphosphonate.
    Rajapakse C, Thompson R, Grennan DM, Winston BM, Patel P, Nuttall PM, Murphy J, Weiss JB.
    Ann Rheum Dis; 1983 Apr 30; 42(2):138-41. PubMed ID: 6221703
    [Abstract] [Full Text] [Related]

  • 16. Bone-to-bone, joint-to-bone and joint-to-joint ratios in normal and diseased skeletal states using region-of-interest technique and bone-seeking radiopharmaceuticals.
    Büll U, Schuster H, Pfeifer JP, Tongendorff J, Niendorf HP.
    Nuklearmedizin; 1977 Jul 30; 16(3):104-12. PubMed ID: 197499
    [Abstract] [Full Text] [Related]

  • 17. Age-related alterations in skeletal metabolism--24-hr whole-body retention of diphosphonate in 250 normal subjects: concise communication.
    Fogelman I, Bessent R.
    J Nucl Med; 1982 Apr 30; 23(4):296-300. PubMed ID: 6802938
    [Abstract] [Full Text] [Related]

  • 18. Splenic accumulation of technetium 99m-methylene diphosphonate.
    Nisbet AP, Maisey MN.
    Br J Radiol; 1982 Jun 30; 55(654):454-5. PubMed ID: 6213282
    [No Abstract] [Full Text] [Related]

  • 19. Abnormalities in bone mineral density distribution and bone scintigraphy in patients with childhood onset hypopituitarism.
    Kosowicz J, El Ali Z, Ziemnicka K, Sowinski J.
    J Clin Densitom; 2007 Jun 30; 10(3):332-9. PubMed ID: 17470407
    [Abstract] [Full Text] [Related]

  • 20. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
    Keyszer G, Lambiri I, Nagel R, Keysser C, Keysser M, Gromnica-Ihle E, Franz J, Burmester GR, Jung K.
    J Rheumatol; 1999 Feb 30; 26(2):251-8. PubMed ID: 9972954
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.